2022
Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study., Elaine M Walsh, Ayca Gucalp, Sujata Patil, Marcia Edelweiss, Dara S Ross, Pedram Razavi, Shanu Modi, Neil M Iyengar, Rachel Sanford, Tiffany Troso-Sandoval, Mila Gorsky, Jacqueline Bromberg, Pamela Drullinsky, Diana Lake, Serena Wong, Patricia Ann DeFusco, Nicholas Lamparella DO, Ranju Gupta, Tasmila Tabassum, Leigh Ann Boyle, Artavazd Arumov, and Tiffany A Traina (Article)
2021
Dale and Frances Hughes Cancer Center Lehigh Valley Hospital–Pocono: 2021 Statistical Report, Lehigh Valley Health Network (Report)
Lehigh Valley Topper Cancer Institute: 2021 Statistical Report, Lehigh Valley Health Network (Report)
2020
Dale & Frances Hughes Cancer Center Lehigh Valley Hospital–Pocono: 2020 Statistical Report, Lehigh Valley Health Network (Report)
Lehigh Valley Topper Cancer Institute: 2020 Statistical Report, Lehigh Valley Health Network (Report)
2019
Lehigh Valley Hospital-Pocono: 2019 Statistical Report, Lehigh Valley Health Network (Report)
Lehigh Valley Topper Cancer Institute: 2019 Statistical Report, Lehigh Valley Health Network (Report)
Su guia para la inmunoterapia, Lehigh Valley Health Network and ACCC Association of Community Cancer Centers (Article)
2018
Lehigh Valley Hospital: Statistical Report 2018, Lehigh Valley Health Network (Report)
Lehigh Valley Topper Cancer Institute: 2018 Statistical Report, Lehigh Valley Health Network (Report)
2017
Your Guide to Immunotherapy, Lehigh Valley Health Network and ACCC Association of Community Cancer Centers (Article)